October 16 - 15:10
Ori Biotech earns $30m in new funding
Ori Biotech wants to accelerate cell and gene therapy manufacturing after raising $30m from a Series A round. The cash injection will allow Ori to take its platform, which leverages automation, to market. The investment was led by Northpond Ventures, an experienced VC firm in the science and medical space. Ori says its mission is to "enable patient access to life-saving cell and gene therapies".
> Tweets